Age-related changes in rodent cortical acetylcholine and cognition: Main effects of age versus age as an intervening variable

Brain Research Reviews

Volumn 27, Issue 2, 1998, Pages 143-156

  Sarter, Martin ^a   Bruno, John P ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

Acetylcholine; Aging; Basal forebrain; Cortex; Rodent

Indexed keywords

ACETYLCHOLINE;

ACETYLCHOLINE BRAIN LEVEL; ACETYLCHOLINE RELEASE; AGING; ANIMAL EXPERIMENT; BRAIN INJURY; CHOLINERGIC TRANSMISSION; COGNITION; DEGENERATIVE DISEASE; DEMENTIA; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW;

ACETYLCHOLINE; AGING; ANIMALS; CARRIER PROTEINS; CEREBRAL CORTEX; CHOLINE; CHOLINE O-ACETYLTRANSFERASE; COGNITION; HUMANS; NERVE TISSUE PROTEINS; NEURONS; PLASMA MEMBRANE NEUROTRANSMITTER TRANSPORT PROTEINS; PROSENCEPHALON; RATS; RODENTIA; SYMPORTERS;

EID: 0031751370     PISSN: 01650173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0173(98)00003-4     Document Type: Review

References (124)

1. Abdulla F.A., Abu-Bakra M.A.J., Calaminici M.-R., Stephenson J.-D., Sinden J.D. Importance of forebrain cholinergic and GABAergic systems to the age-related deficits in water maze performance of rats. Neurobiol. Aging. 16:1995;41-52.
2. Alberch J.E., Perez-Navarro E., Arenas E., Marsal J. Involvement of nerve growth factor and its receptor in the regulation of the cholinergic function in aged rats. J. Neurochem. 57:1991;1483-1487.
3. Altavista M.C., Rossi P., Bentivoglio A.R., Crociani P., Albanese A. Aging is associated with a diffuse impairment of forebrain cholinergic neurons. Brain Res. 508:1990;51-59.
4. Araujo D.M., Lapchak P.A., Meaney M.J., Collier B., Quirion R. Effects of aging on nicotinic and muscarinic autoreceptor function in the rat brain: relationship to presynaptic cholinergic markers and binding sites. J. Neurosci. 10:1990;3069-3078.
5. Arendt T., Marcova L., Bigl V., Brückner M.K. Dendritic reorganization in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease: I. Dendritic organization of the normal human basal forebrain. J. Comp. Neurol. 151:1995;169-188.
6. Arendt T., Brückner M.K., Bigl V., Marcova L. Dendritic reorganization in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease: II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease. J. Comp. Neurol. 151:1995;189-222.
7. Arendt T., Brückner M.K., Bigl V., Marcova L. Dendritic reorganization in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease: III. The basal forebrain compared with other subcortical areas. J. Comp. Neurol. 151:1995;169-188.
8. Armstrong D.M., Sheffield R., Buzsaki G., Chen K., Hersh L.B., Nearing B., Gage F.H. Morphologic alterations of choline acetyltransferase-positive neurons in the basal forebrain of aged behaviorally characterized Fisher 344 rats. Neurobiol. Aging. 14:1993;457-470.
9. Aubert I., Rowe W., Meaney M.J., Gauthier S., Quirion R. Cholinergic markers in aged cognitively impaired Long-Evans rats. Neuroscience. 67:1995;277-292.
10. Bartus R.T., Dean R.L. III, Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-417.
11. Baxter M.G., Bucci D.J., Gorman L., Wiley R.G., Gallagher M. Selective immunotoxic lesions of basal forebrain cholinergic cells: effects on learning and memory in rats. Behav. Neurosci. 109:1995;714-722.
12. Biegon A., Duvdevani R., Greenberger V., Segal M. Aging and brain cholinergic muscarinic receptors: an autoradiographic study in the rat. J. Neurochem. 51:1988;1381-1385.
13. Biegon A., Greenberger V., Segal M. Quantitative histochemistry of brain acetylcholinesterase and learning rate in the aged rat. Neurobiol. Aging. 7:1986;215-217.
14. Bigl V., Arendt T., Fischer S., Fischer S., Werner M., Arendt A. The cholinergic system in aging. Gerontology. 33:1987;172-180.
15. Blusztajn J.K., Wurtman R.J. Choline and cholinergic neurons. Science. 221:1983;614-620.
16. Butcher L.L., Semba K. Reassessing the cholinergic basal forebrain: nomenclature schemata and concepts. Trends Neurosci. 12:1989;483-485.
17. Casamenti F., Scali C., Pepeu G. Phosphatidylserine reverses the age-dependent decrease in cortical acetylcholine release: a microdialysis study. Eur. J. Pharmacol. 194:1991;11-16.
18. Coleman P., Finch C., Joseph J. The need for multiple time points in aging studies. Neurobiol. Aging. 11:1990;1-2.
19. Collerton D. Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience. 19:1986;1-28.
20. Collier T.J., Coleman P.D. Divergence of biological and chronological aging: evidence from rodent studies. Neurobiol. Aging. 12:1991;685-693.
21. Connor D.J., Thal L.J., Mandel R.J., Langlais P.J., Masliah E. Independent effects of age and nucleus basalis magnocellularis lesion: maze learning, cortical neurochemistry, and morphometry. Behav. Neurosci. 106:1992;776-788.
22. Cooper J.R. Unsolved problems in the cholinergic nervous system. J. Neurochem. 63:1994;395-399.
23. Dekker J.A.M., Connor D.J., Thal L.J. The role of cholinergic projections from the nucleus basalis in memory. Neurosci. Biobehav. Rev. 15:1991;299-317.
24. Intraventricular Bethanecol Study Group, DeKosky S.T., Harbaugh R.E., Schmitt F.A., Bakay R.A., Chiu H.C., Knopman D.S., Reeder T.M., Shetter A.G., Senter H.J., Markesberry W.R. Cortical biopsy in Alzheimer's disease: diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Ann. Neurol. 32:1992;625-632.
25. De Lacalle S., Cooper J.D., Svendsen C.N., Dunnett S.B., Sofroniew M.V. Reduced retrograde labelling with fluorescent tracer accompanies neuronal atrophy of basal forebrain cholinergic neurons in aged rats. Neuroscience. 75:1996;19-27.
26. De Lacalle S., Iraizoz I., MaGonzalo L. Differential changes in cell size and number in topographic subdivisions of human basal nucleus in normal aging. Neuroscience. 43:1991;445-456.
27. Dewey S.L., Volkow N.D., Logan J., MacGregor R.R., Fowler J.S., Schlyer D.J., Bendriem B. Age-related decreases in muscarinic cholinergic receptor binding in the human brain measured with positron emission tomography (PET). J. Neurosci. Res. 27:1990;569-575.
28. Etienne P., Robitaille Y., Wood P., Gauthier S., Nair N.P.V., Quirion R. Nucleus basalis neuronal loss, neuritic plaques and choline acetyltransferase activity in advanced Alzheimer's disease. Neuroscience. 19:1986;1279-1291.
29. Fadel J., Moore H., Sarter M., Bruno J.P. Trans-synaptic stimulation of cortical acetylcholine release after partial 192 IgG-saporin-induced loss of cortical cholinergic afferents. J. Neurosci. 15:1996;6592-6600.
30. Fadel J., Sarter M., Bruno J.P. Interactions between the effects of age and cholinergic lesions on cortical acetylcholine release. Soc. Neurosci. Abstr. 22:1996;173.13.
31. Fibiger H.C. The organization and some projections of cholinergic neurons of the mammalian forebrain. Brain Res. Rev. 4:1982;327-388.
32. H.C. Fibiger, Cholinergic mechanisms in learning, memory and dementia: a review of recent evidence, Trends Neurosci. (1991) 220-223.
33. Fischer W., Chen K., Gage F.H., Björklund A. Progressive decline in spatial learning and integrity of forebrain cholinergic neurons in rats during aging. Neurobiol. Aging. 13:1991;9-23.
34. Fonnum F. Topographical and subcellular localisation of choline acetyl transferase in rat hippocampal region. J. Neurochem. 17:1970;1029-1037.
35. Gallagher M. Issues in the development of models for cognitive aging across primate and nonprimate species. Neurobiol. Aging. 14:1993;631-633.
36. Gallagher M., Colombo P.J. Ageing: the cholinergic hypothesis of cognitive decline. Curr. Opin. Neurobiol. 5:1995;161-168.
37. Gallagher M., Landfield P.W., McEwen B., Meaney M.J., Rapp P.R., Sapolsky R., West M. Hippocampal neurodegeneration in aging. Science. 274:1996;484-485.
38. Geula C., Mesulam M.-M. Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease. Cereb. Cortex. 6:1996;165-177.
39. Givens B.S., Sarter M. Modulation of cognitive processes by transsynaptic activation of the basal forebrain. Behav. Brain Res. 84:1997;1-22.
40. Haba K., Ogawa N., Kawata M., Mori A. A method for parallel determination of choline acetyltransferase and muscarinic cholinergic receptors: application in aged-rat brain. Neurochem. Res. 13:1988;951-955.
41. Hellweg R., Fischer W., Hock C., Gage F.H., Björklund A., Thoenen H. Nerve growth factor levels and choline acetyltransferase activity in the brain of aged rats with spatial memory impairments. Brain Res. 537:1990;123-130.
42. Himmelheber A.M., Sarter M., Bruno J.P. Operant performance and cortical acetylcholine release: role of response rate, reward density, and non-contingent stimuli. Cogn. Brain Res. 6:1997;23-36.
43. Holley L.A., Wiley R.G., Lappi D.A., Sarter M. Cortical cholinergic deafferentation following intracortical infusion of 192 IgG-saporin: a quantitative histochemical study. Brain Res. 663:1994;277-286.
44. Hornberger J.C., Buell S.J., Flood D.G., McNeill T.H., Coleman P.D. Stability of numbers but not size of mouse forebrain cholinergic neurons to 53 months. Neurobiol. Aging. 6:1985;269-275.
45. Ingram D.K., London E.D., Goodrick C.L. Age and neurochemical correlates of radial maze performance in rats. Neurobiol. Aging. 2:1981;41-47.
46. Iraizoz I., De Lacalle S., Gonzalo L.M. Cell loss and nuclear hypertrophy in topographical subdivisions of the nucleus basalis of Meynert in Alzheimer's disease. Neuroscience. 41:1991;33-40.
47. +-evoked release of endogenous striatal dopamine: an indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence. Brain Res. 454:1988;140-148.
48. Joseph J.A., Roth G.S. Loss of muscarinic regulation of striatal dopamine function in senescence. Neurochem. Int. 20:1992;237S-240S.
49. Kaye J.A., Swihart T., Howieson D., Dame A., Moore M.M., Karnos T., Camicioli R., Ball M., Oken B., Sexton G. Volume loss of hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology. 48:1997;1297-1304.
50. Kellar K.J., Whitehouse P.J., Martino-Barrows A.M., Marcus K., Price D.L. Muscarinic and nicotinic cholinergic binding sites in Alzheimer's disease cerebral cortex. Brain Res. 436:1987;62-68.
51. Kesner R.P. Reevaluation of the contribution of the basal forebrain cholinergic system to memory. Neurobiol. Aging. 9:1988;609-616.
52. Kubanis P., Zornetzer S.F., Freund G. Memory and postsynaptic cholinergic receptors in aging mice. Pharmacol. Biochem. Behav. 17:1982;313-322.
53. Kurosawa M., Sato A., Sato Y. Well-maintained responses of acetylcholine release and blood flow in the cerebral cortex to focal electrical stimulation of the nucleus basalis of Meynert in aged rats. Neurosci. Lett. 100:1989;198-202.
54. Lebrun C., Durkin T.P., Marighetto A., Jaffard R. A comparison of the working memory performances of young and aged mice combined with parallel measures of testing and drug-induced activations of septo-hippocampal and nbm-cortical cholinergic neurones. Neurobiol. Aging. 11:1990;515-521.
55. Lehericy S., Hirsch E., Cervera-Pierot P., Hersh L.B., Bakchine S., Piette F., Duyckaerts C., Hauw J.J., Javoy-Agid F., Agid Y. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. J. Comp. Neurol. 330:1993;15-31.
56. Lippa A.S., Loullis C.C., Rotrosen J., Cordasco D.M., Critchett D.J., Joseph J.A. Conformational changes in muscarinic receptors may produce diminished cholinergic neurotransmission and memory deficits in aged rats. Neurobiol. Aging. 6:1985;317-323.
57. Lippa A.S., Pelham R.W., Beer B., Critchett D.J., Dean R.L., Bartus R.T. Brain cholinergic dysfunction and memory in aged rats. Neurobiol. Aging. 1:1980;13-19.
58. Luine V., Hearns M. Spatial memory deficits in aged rats: contributions of the cholinergic system assessed by ChAT. Brain Res. 523:1990;321-324.
59. Luine V.N., Renner K.J., Heady S., Jones K.J. Age- and sex-dependent decreases in ChAT in basal forebrain nuclei. Neurobiol. Aging. 7:1986;193-198.
60. Mash D.C., Flynn D.D., Potter L.T. Loss of M2 muscarinic receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science. 228:1985;1115-1117.
61. McGaughy J., Kaiser T., Sarter M. Behavioral vigilance following infusions of 192 IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical ACh-positive fiber density. Behav. Neurosci. 110:1996;247-265.
62. McGeer P.L., McGeer E.G., Suzuki J., Dolman C.E., Nagai T. Aging, Alzheimer's disease, and the cholinergic system of the basal forebrain. Neurology. 34:1984;741-745.
63. N. Mestre, N. Bons, Age-related cytological changes and neuronal loss in basal forebrain cholinergic neurons in Micorcebus murinus (lemurian, primate), Neurodegeneration 2, 25-32.
64. Mesulam M.-M., Mufson E.J., Rogers J. Age-related shrinkage of cortically projecting cholinergic neurons: a selective effect. Ann. Neurol. 22:1987;31-36.
65. Meyer E.M., Crews F.T., Otero D.H., Larsen K. Aging decreases the sensitivity of rat cortical synaptosomes to calcium ionophore-induced acetylcholine release. J. Neurochem. 47:1986;1244-1246.
66. Meyer E.M., St. Onge E., Crews F.T. Effects of aging on rat cortical presynaptic cholinergic processes. Neurobiol. Aging. 5:1984;315-317.
67. Michalek H., Fortuna S., Pintor A. Age-related differences in brain choline acetyltransferase, cholinesterases and muscarinic receptor sites in two strains of rats. Neurobiol. Aging. 10:1989;143-148.
68. Mitsushima D., Mizuno T., Kimura F. Age-related changes in diurnal acetylcholine release in the prefrontal cortex of male rats as measured by microdialysis. Neuroscience. 72:1996;429-434.
69. Moore H., Sarter M., Bruno J.P. Age-dependent modulation of in vivo cortical acetylcholine release by benzodiazepine receptor ligands. Brain Res. 596:1992;17-29.
70. Moore H., Stuckman S., Sarter M., Bruno J.P. Potassium- but not atropine-stimulated cortical acetylcholine efflux is reduced in aged rats. Neurobiol. Aging. 17:1996;571-656.
71. Mufson E.J., Li J.M., Sobreviela T., Kordower J.H. Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease. NeuroReport. 8:1996;25-29.
72. Muir J.L. Acetylcholine, aging, and Alzheimer's disease. Pharmacol. Biochem. Behav. 56:1997;687-696.
73. Nakamura S., Ishihara T. Region of selective increase in activities of CNS cholinergic marker enzymes during learning of memory tasks in aged rats. Pharmacol. Biochem. Behav. 34:1989;805-810.
74. Nakamura S., Ohno T. Spatial learning impairment in aged rats: comparing between aged basal forebrain lesioned and normal aged rats. Behav. Brain Res. 70:1995;69-76.
75. Nordberg A., Alafuzoff I., Winblad B. Nicotinic and muscarinic subtypes in the human brain: changes with aging and dementia. J. Neurosci. Res. 31:1992;102-111.
76. Palmer A.M. Neurochemical studies of Alzheimer's disease. Neurodegeneration. 5:1996;381-391.
77. Palmer A.M., Francis P.T., Benton J.S., Sims N.R., Mann D.M.A., Neary D., Snowdon J.S., Bowen D.M. Presynaptic serotonergic dysfunction in patients with Alzheimer's disease. J. Neurochem. 48:1987;8-15.
78. Palmer A.M., Francis P.T., Bowen D.M., Benton J.S., Neary D., Mann D.M.A., Snowdon J.S. Catecholaminergic neurons assessed antemortem in Alzheimer's disease. Brain Res. 414:1987;365-375.
79. Pedata F., Slavikova J., Kotas A., Pepeu G. Acetylcholine release from rat cortical slices during postnatal development and aging. Neurobiol. Aging. 4:1983;31-35.
80. Perry E.K. The cholinergic hypothesis - ten years on. Br. Med. Bull. 42:1986;63-65.
81. Perry E.K., Blessed G., Tomlinson B.E., Perry R.H., Crow T.J., Cross A.J., Dockray G.J., Dimaline R., Arregui A. Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes. Neurobiol. Aging. 2:1981;251-256.
82. Perry E.K., Johnson M., Kerwin J.M., Piggott M.A., Court J.A., Shaw P.J., Ince P.G., Brown A., Perry R.H. Convergent cholinergic activities in aging and Alzheimer's disease. Neurobiol. Aging. 13:1992;393-400.
83. Perry E.K., Tomlinson B.E., Blessed G., Bergmann K., Gibson P.H., Perry R.H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 2:1987;1457-1459.
84. 1 hybrids. J. Gerontol. 49:1994;B1-B11.
85. Riekkinen P. Jr., Riekkinen M., Sirviö J., Miettinen R., Riekkinen P. Loss of cholinergic neurons in the nucleus basalis induces neocortical electroencephalographic and passive avoidance deficits. Neuroscience. 47:1992;823-831.
86. Rinne J.O., Lönnberg P., Marjamäki P., Rinne U.K. Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease. Brain Res. 483:1989;402-406.
87. Rogers J. Efficient experimental design in aging studies. Neurobiol. Aging. 12:1991;695-697.
88. Rosene D.L. Comparing age-related changes in the basal forebrain and hippocampus of the rhesus monkey. Neurobiol. Aging. 14:1993;669-670.
89. Saleh A., Verhaagen J., Dijkhuizen P.A., Swaab D.F. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience. 75:1996;373-387.
90. Sarter M., Bruno J.P. Cognitive functions of cortical acetylcholine: lesions from studies on the trans-synaptic modulation of activated efflux. Trends Neurosci. 17:1994;217-222.
91. Sarter M., Bruno J.P. Trans-synaptic stimulation of cortical acetylcholine and attention: a rationale approach for the development of cognition enhancers. Behav. Brain Res. 83:1997;7-15.
92. M. Sarter, J.P. Bruno, Cortical acetylcholine, attention, and neuropharmacological and cognitive principles directing treatment strategies for cognitive disorders, in: J.E. Brioni, M.W. Decker (Eds.), Pharmacological Treatment of Alzheimer's Disease: Molecular and Neurobiological Foundations, Wiley-Liss, New York, 1997, pp. 105-128.
93. Sarter M., Bruno J.P. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res. Rev. 23:1997;28-46.
94. Sarter M., Bruno J.P., Givens B.S., Moore H., McGaughy J., McMahon K. Neuronal mechanisms of drug effects on cognition: cognitive activity as a necessary intervening variable. Cogn. Brain Res. 3:1996;329-343.
95. Sarter M., Schneider H.H., Stephens D.N. Treatment strategies for senile dementia: antagonist β-carbolines. Trends Neurosci. 11:1988;13-17.
96. Schmidt B.M., Rylett R.J. Basal synthesis of acetylcholine in hippocampal synaptosomes is not dependent upon membrane-bound choline acetyltransferase activity. Neuroscience. 54:1993;649-656.
97. Schröder H., Giacobini E., Struble R.G., Luiten P.G.M., van der Zee E.A., Zilles K., Strosberg A.D. Muscarinic cholinoceptive neurons in the frontal cortex in Alzheimer's disease. Brain Res. Bull. 27:1991;631-636.
98. Schwartz R.D., Bernabei A.A., Spencer C.J., Pugsley T.A. Loss of muscarinic M1 receptors with aging in the cerebral cortex of Fisher 344 rats. Pharmacol. Biochem. Behav. 35:1990;589-593.
99. 3H-choline in the cerebral cortex of ageing male rats. Pharmacol. Toxicol. 62:1988;227-229.
100. Smith T.D., Gallagher M., Leslie F.M. Cholinergic binding sites in rat brain: analysis by age and cognitive status. Neurobiol. Aging. 16:1995;161-173.
101. 1 hybrid. Neurobiol. Aging. 15:1994;319-328.
102. Sparks D.L., Hunsaker J.C., Slevin J.T., DeKosky S.T., Kryscio R.J., Markesberry W.R. Monoaminergic and cholinergic synaptic markers in the nucleus basalis of Meynert (nbM): normal age-related changes and the effect of heart disease and Alzheimer's disease. Ann. Neurol. 31:1992;611-620.
103. Stephens P.H., Tagari P.C., Cuello A.C. Age-related variations in plasticity of rat basal forebrain cholinergic neurons after cortical lesions. Brain Res. 448:1988;320-324.
104. Stoehr J.D., Wenk G.L. Effects of age and lesions of the nucleus basalis on contextual fear conditioning. Psychobiology. 23:1995;173-177.
105. Stone W.S., Altman H.J., Berman R.F., Caldwell D.F., Kilbey M.M. Association of sleep parameters and memory in intact old rats and young rats with lesions in the nucleus basalis magnocellularis. Behav. Neurosci. 103:1989;755-764.
106. Strong R., Hicks P., Hsu L., Bartus R.T., Enna J. Age-related alterations in the rodent brain cholinergic system and behavior. Neurobiol. Aging. 1:1980;59-63.
107. Suhura T., Inoue O., Kobayashi K., Suzuki K., Tateno Y. Age-related changes in human muscarinic acetylcholine receptors measured by positron emission tomography. Neurosci. Lett. 149:1993;225-228.
108. Surichamorn W., Kim O.N., Lee N.H., Lai W.S., El-Fakahany E.E. Effects of aging on the interaction of quinuclidinyl benzilate, N-methylscopolamine, pirenzepine, and gallanine with brain muscarinic receptors. Neurochem. Res. 13:1988;1183-1191.
109. Tandon P., Mundy W.R., Ali S.F., Nanry K., Rogers B.C., Tilson H.A. Age-dependent changes in receptor-stimulated phosphoinositide turnover in the rat hippocampus. Pharmacol. Biochem. Behav. 38:1991;861-867.
110. Tamer A.E., Wulfert E., Hanin I. Age-dependent effect of AF64A on cholinergic activity in the septo-hippocampal pathway of the rat brain: decreased responsiveness in aged rats. Neurosci. Lett. 203:1996;123-126.
111. Thal L.J., Gilbertson E., Armstrong D.M., Gage F.H. Development of the basal forebrain cholinergic system: phenotype expression prior to target innervation. Neurobiol. Aging. 13:1991;67-72.
112. Torres E.M., Perry T.A., Blokland A., Wilkinson L.S., Wiley R.G., Lappi D.A., Dunnett S.B. Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system. Neuroscience. 63:1994;95-122.
113. Tucek S. Observations on the subcellular distribution of choline acetyltransferase in the brain tissue of mammals and comparisons of acetylcholine synthesis from acetate and citrate in homogenates and nerve-ending fractions. J. Neurochem. 14:1967;519-529.
114. Turchi J., Sarter M. Cortical acetylcholine and processing capacity: effects of cortical cholinergic deafferentation on crossmodal divided attention in rats. Cogn. Brain Res. 6:1997;147-158.
115. Unger J.W., Schmidt Y. Quisqualic acid-induced lesion of the nucleus basalis of Meynert in young and aging rats: plasticity of surviving NGF receptor-positive cholinergic neurons. Exp. Neurol. 117:1992;269-277.
116. Vinson P.N., Justice J.B. Jr. Effect of neostigmine on concentration and extraction of acetylcholine using quantitative microdialysis. J. Neurosci. Methods. 73:1997;61-67.
117. Voytko M.L., Suhkov R.R., Walker L.C., Breckler S.J., Price D.L., Koliatsos V.E. Neuronal number and size are preserved in the nucleus basalis of aged rhesus Monkeys. Dementia. 6:1995;131-141.
118. Waller S.B., London E.D. Choline acetyltransferase activity and muscarinic binding in brain regions of aging Fischer-344 rats. Neurochem. Int. 14:1989;483-490.
119. Wenk G.L., Stoehr J.D., Quintana G., Mobley S., Wiley R.G. Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into the basal forebrain of rats. J. Neurosci. 14:1994;5986-5995.
120. Wenk G.L., Stoehr J.D., Mobley S.L., Gurney J., Morris R.J. Age-related decrease in vulnerability to excitatory amino acids in the nucleus basalis. Neurobiol. Aging. 17:1995;1-7.
121. Whitehouse P.J., Price D.L., Struble R.G., Clark A.W., Coyle J., Delong M.R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 215:1981;1237-1239.
122. N.J. Woolf, L.L. Butcher, Dysdifferentiation of structurally plastic neurons initiates the pathologic cascade of Alzheimer's disease: toward a unifying hypothesis, in: M. Steriade, D. Biesold (Eds.), Brain Cholinergic Systems, Oxford Univ. Press, Oxford, 1990, pp. 386-438.
123. Wu C.F., Bertorelli R., Sacconi M., Pepeu G., Consolo S. Decrease of brain acetylcholine release in aging freely-moving rats detected by microdialysis. Neurobiol. Aging. 9:1988;357-361.
124. Zawia N., Arendash G.W., Wecker L. Basal forebrain cholinergic neurons in aged rat brain are more susceptible to ibotenate-induced degeneration than neurons in young adult brain. Brain Res. 589:1992;333-337.